162 related articles for article (PubMed ID: 30428914)
1. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
Marini F; Giusti F; Brandi ML
Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
[TBL] [Abstract][Full Text] [Related]
2. A Japanese Family Meeting the Clinical Diagnostic Criteria for MEN1 with a MEN1 Variant of Uncertain Significance.
Matsubayashi H; Kiyozumi Y; Harada R; Mukaigawa T; Sugiura T; Ishiwatari H; Sato J; Niiya F; Nakashima K; Kado N; Nishimura S; Honda G; Ohike N
Intern Med; 2024 Apr; 63(8):1119-1123. PubMed ID: 37661450
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism].
Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
[TBL] [Abstract][Full Text] [Related]
4. Genetic disorders and insulinoma/glucagonoma.
Marini F; Giusti F; Brandi ML
Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
[TBL] [Abstract][Full Text] [Related]
5. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract][Full Text] [Related]
6. Multifocal Insulinoma as the Unique Presenting Feature of MEN1 in an Adolescent.
Murray A; Rodas Marquez SP; Krishnamurthy M; Lopez-Nunez O; Gurria JP; Trout AT; Almazan S; Mutyala K; Shah A; Howell J
Horm Res Paediatr; 2024 Mar; ():. PubMed ID: 38442699
[TBL] [Abstract][Full Text] [Related]
7. Lived experiences of undergoing regular tumor screening in patients with multiple endocrine neoplasia types 1 and 2 (MEN1/MEN2).
Klein Haneveld MJ; Valk GD; van Leeuwaarde RS
J Genet Couns; 2024 Apr; 33(2):402-412. PubMed ID: 37357885
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Neoplasia: From Pathophysiology to Novel Therapeutic Approaches.
Carsote M; Nistor C
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672156
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of mosaic mutations in the MEN1 gene by next generation sequencing.
Coppin L; Ferrière A; Crépin M; Haissaguerre M; Ladsous M; Tabarin A; Odou MF
Eur J Endocrinol; 2019 Feb; 180(2):L1-L3. PubMed ID: 30444722
[No Abstract] [Full Text] [Related]
10. Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome.
Beijers HJBH; Stikkelbroeck NML; Mensenkamp AR; Pfundt R; van der Luijt RB; Timmers HJLM; Hermus ARMM; Kempers MJE
Eur J Endocrinol; 2019 Feb; 180(2):K15-K19. PubMed ID: 30481156
[TBL] [Abstract][Full Text] [Related]
11. Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis.
Kamilaris CDC; Stratakis CA
Front Endocrinol (Lausanne); 2019; 10():339. PubMed ID: 31263451
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
Tonelli F; Marini F; Giusti F; Iantomasi T; Giudici F; Brandi ML
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894286
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.
Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
[TBL] [Abstract][Full Text] [Related]
14. The Russian registry of primary hyperparathyroidism, latest update.
Mokrysheva NG; Eremkina AK; Elfimova AR; Kovaleva EV; Miliutina AP; Bibik EE; Gorbacheva AM; Dobreva EA; Maganeva IS; Krupinova JA; Salimkhanov RH; Aboishava LA; Karaseva EV; Melnichenko GA; Dedov II
Front Endocrinol (Lausanne); 2023; 14():1203437. PubMed ID: 37465121
[TBL] [Abstract][Full Text] [Related]
15. Brain and/or Spinal Cord Tumors Accompanied with Other Diseases or Syndromes.
Capitanio JF; Mortini P
Adv Exp Med Biol; 2023; 1405():645-672. PubMed ID: 37452957
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract][Full Text] [Related]
17. Multiple Endocrine Neoplasia Type 1 Syndrome Pancreatic Neuroendocrine Tumor Genotype/Phenotype: Is There Any Advance on Predicting or Preventing?
Ramamoorthy B; Nilubol N
Surg Oncol Clin N Am; 2023 Apr; 32(2):315-325. PubMed ID: 36925188
[TBL] [Abstract][Full Text] [Related]
18. Approach of Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome-Related Skin Tumors.
Băicoianu-Nițescu LC; Gheorghe AM; Carsote M; Dumitrascu MC; Sandru F
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428828
[TBL] [Abstract][Full Text] [Related]
19. Beyond the "3 Ps": A critical appraisal of the non-endocrine manifestations of multiple endocrine neoplasia type 1.
Waguespack SG
Front Endocrinol (Lausanne); 2022; 13():1029041. PubMed ID: 36325452
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.
Zhao Y; Yu J; Liu Y; Lyu L; Ping F; Xu L; Li W; Wang O; Xu Q; Wu W; Zhang H; Li Y
Orphanet J Rare Dis; 2022 Jun; 17(1):219. PubMed ID: 35698198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
